India on Tuesday added over 8,000 new Covid-19 cases for the third day in a row, even as the Drugs Controller General of India (DCGI) granted US pharma giant Gilead Sciences marketing authorisation for its anti-viral drug remdesivir for “restricted emergency use” on hospitalised Covid-19 patients.
“We have reviewed evidence on basis of which remdesivir has been given emergency approval for use in Covid-19 patients,” said Lav Agarwal, Joint Secretary, Ministry of Health and Family Welfare (MoHFW).
India now has 1,98,706 confirmed cases, of which about 48 per cent, or 95,527 individuals, have recovered, said MoHFW.
Maharashtra continues to hold the record for the largest number of cases. On Tuesday, its tally crossed the 70,000-mark, with 70,013 cases, of which 30,108 have recovered. At 43 per cent, its recovery rate is slightly lower than the national average. About 2,362 people have died of the disease in the State.
Delhi crossed the 20,000-mark with 20,834 cases on June 2. Of these, 8,746 (42 per cent) have recovered while 523 have died. At present, 2,748 patients are admitted in over 15 hospitals across Delhi, of which 219 are in ICU and 42 are on ventilator.
Another 164 positive cases with mild symptoms have been admitted to dedicated Covid-19 health centres, while 672 others have been quarantined in nine dedicated care centres that are mostly government flats, hostels and a hotel. The Delhi government provided a break-up of 50 audited dezaths between April 7 and May 31; of these, the maximum, 10, occurred on May 30. Around 6,238 others are in home isolation.
Gujarat, among the four worst affected States/UTs, has recorded up to 17,200 cases, of which around 10,780 (62 per cent) have recovered. Though the State has recorded 1,063 deaths, its recovery rate is way above the national average.
Agarwal said all States have been provided with a projection tool to understand the potential rise in cases and the infrastructural preparedness that they will need to maintain.
A letter from the Editor
Dear Readers,
The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.
Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.
In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.
We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.
But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.
I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.
A little help from you can make a huge difference to the cause of quality journalism!
Support Quality Journalism
